NO20024988L - Formulering som har mobiliserende aktivitet - Google Patents

Formulering som har mobiliserende aktivitet

Info

Publication number
NO20024988L
NO20024988L NO20024988A NO20024988A NO20024988L NO 20024988 L NO20024988 L NO 20024988L NO 20024988 A NO20024988 A NO 20024988A NO 20024988 A NO20024988 A NO 20024988A NO 20024988 L NO20024988 L NO 20024988L
Authority
NO
Norway
Prior art keywords
formulation
mobilizing activity
haematopoietic
mobilizing
activity
Prior art date
Application number
NO20024988A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024988D0 (no
Inventor
Laura Ferro
Roberto Porta
Massimo Iacobelli
Alessandro Massimo Gianni
Carmelo Carlo Stella
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of NO20024988D0 publication Critical patent/NO20024988D0/no
Publication of NO20024988L publication Critical patent/NO20024988L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20024988A 2000-04-18 2002-10-16 Formulering som har mobiliserende aktivitet NO20024988L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00830293A EP1147777A1 (en) 2000-04-18 2000-04-18 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en) 2000-04-18 2001-04-10 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (2)

Publication Number Publication Date
NO20024988D0 NO20024988D0 (no) 2002-10-16
NO20024988L true NO20024988L (no) 2002-12-02

Family

ID=8175292

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024988A NO20024988L (no) 2000-04-18 2002-10-16 Formulering som har mobiliserende aktivitet

Country Status (31)

Country Link
US (1) US20040131588A1 (sl)
EP (3) EP1147777A1 (sl)
JP (1) JP5205668B2 (sl)
KR (1) KR100849491B1 (sl)
CN (1) CN1183962C (sl)
AT (2) ATE310532T1 (sl)
AU (2) AU5832201A (sl)
BG (1) BG107203A (sl)
CA (1) CA2406179C (sl)
CY (1) CY1104971T1 (sl)
CZ (1) CZ20023426A3 (sl)
DE (2) DE60115222T2 (sl)
DK (2) DK1276497T3 (sl)
EE (1) EE200200596A (sl)
ES (2) ES2252227T3 (sl)
HR (1) HRP20020835A2 (sl)
HU (1) HUP0300560A3 (sl)
IL (1) IL152328A (sl)
IS (1) IS2171B (sl)
MX (1) MXPA02010346A (sl)
NO (1) NO20024988L (sl)
NZ (1) NZ522016A (sl)
PL (1) PL358100A1 (sl)
PT (1) PT1621207E (sl)
RO (1) RO121006B1 (sl)
RU (1) RU2248216C2 (sl)
SI (1) SI21079B (sl)
SK (1) SK14892002A3 (sl)
UA (1) UA73566C2 (sl)
WO (1) WO2001078761A2 (sl)
ZA (1) ZA200208413B (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
WO2005017160A2 (en) * 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
WO2005017161A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Chimeric peptides for the regulation of gtpases
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) * 2008-07-17 2009-12-27 Владислав Николаевич Ласкавый Средство для активации стволовых клеток
ES2694239T3 (es) 2010-11-12 2018-12-19 Gentium S.R.L. Defibrótido para su uso en profilaxis y/o tratamiento de la enfermedad de Injerto contra huésped (GVHD)
CA2874960C (en) 2012-06-22 2021-05-18 Gentium S.P.A. Euglobulin-based method for determining the biological activity of defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) * 2016-11-14 2017-04-19 北京国泰通源技术有限公司 智能控水短节
CN110352246A (zh) * 2018-01-12 2019-10-18 赛尔美格公司 产生细胞囊和细胞囊管的方法
KR20220071274A (ko) 2019-11-13 2022-05-31 후지필름 가부시키가이샤 가식 필름, 성형물, 및 전자 디바이스

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154279A1 (de) 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1206341B (it) 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en) 1985-05-28 1987-09-15 Ajax Magnethermic Corporation Apparatus for overheating edges of skelp for the production of compression welded pipe
IT1190313B (it) 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
US5223609A (en) 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) * 1988-08-24 1999-06-21 中外製薬株式会社 抗血栓剤
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) * 1992-01-28 2000-03-15 松下電器産業株式会社 電動調理機
JPH08127539A (ja) * 1994-10-31 1996-05-21 Ajinomoto Co Inc ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
WO1996016987A1 (fr) * 1994-11-30 1996-06-06 Chugai Seiyaku Kabushiki Kaisha Facteur thrombocytotique
ATE299030T1 (de) * 1996-07-10 2005-07-15 Meiji Dairies Corp Verwendung von proteinen aus der mk familie als hämatopoietischer faktor
AU1705599A (en) * 1997-11-26 1999-06-15 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) * 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of

Also Published As

Publication number Publication date
JP5205668B2 (ja) 2013-06-05
BG107203A (bg) 2003-05-30
AU2001258322B2 (en) 2006-03-16
DE60140015D1 (de) 2009-11-05
RU2002130719A (ru) 2004-03-27
CZ20023426A3 (cs) 2003-05-14
IL152328A0 (en) 2003-05-29
EP1276497B1 (en) 2005-11-23
HRP20020835A2 (en) 2005-10-31
NZ522016A (en) 2004-10-29
EE200200596A (et) 2004-04-15
CA2406179A1 (en) 2001-10-25
EP1276497A2 (en) 2003-01-22
EP1621207B1 (en) 2009-09-23
EP1147777A1 (en) 2001-10-24
EP1621207A3 (en) 2006-11-22
KR100849491B1 (ko) 2008-07-31
IS6581A (is) 2002-10-14
CA2406179C (en) 2012-03-27
EP1621207A2 (en) 2006-02-01
ATE310532T1 (de) 2005-12-15
SI21079A (sl) 2003-06-30
CN1183962C (zh) 2005-01-12
DE60115222D1 (de) 2005-12-29
RU2248216C2 (ru) 2005-03-20
RO121006B1 (ro) 2006-11-30
DK1276497T3 (da) 2006-03-27
CY1104971T1 (el) 2010-03-03
ES2335776T3 (es) 2010-04-05
WO2001078761A2 (en) 2001-10-25
HUP0300560A2 (hu) 2003-06-28
NO20024988D0 (no) 2002-10-16
JP2004500437A (ja) 2004-01-08
IS2171B (is) 2006-11-15
IL152328A (en) 2009-12-24
KR20030010603A (ko) 2003-02-05
SK14892002A3 (sk) 2003-06-03
MXPA02010346A (es) 2004-09-06
WO2001078761A3 (en) 2002-01-24
ATE443524T1 (de) 2009-10-15
PL358100A1 (en) 2004-08-09
DE60115222T2 (de) 2006-08-10
AU5832201A (en) 2001-10-30
SI21079B (sl) 2006-08-31
UA73566C2 (en) 2005-08-15
CN1434719A (zh) 2003-08-06
ES2252227T3 (es) 2006-05-16
PT1621207E (pt) 2009-12-28
DK1621207T3 (da) 2010-02-01
ZA200208413B (en) 2003-10-17
US20040131588A1 (en) 2004-07-08
HUP0300560A3 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
NO20024988D0 (no) Formulering som har mobiliserende aktivitet
DE60016670D1 (de) Kosmetisches Mittel enthaltend mindestens einen Hydroxystilben und Ascorbinsäure
NO20061095L (no) Vertscelle som fremstiller chimerisk anti-CD2o-antistoff samt anvendelse derav ved fremstilling av medikamenter til behandling av lidelser som involverer B-celler
DE60143477D1 (de) Verminderung der nebenwirkungen bei der oxybutynin-therapie
DK0774005T3 (da) Overfladeudtrykkelse af enzymer i genorienteret prodrug-terapi
DE69905368T2 (de) Oxydiertes thymosin beta 4
DE69932248D1 (de) Entzündungshemmende ascorbinsäurederivate
DK261490D0 (da) New pharmaceutical compound
AU2001269688A1 (en) Combination containing an antifolate and methylmalonic acid lowering agent
IL158155A0 (en) Use of erythropoietin to ameliorate chemotherapy-induced toxicity in vivo
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
YU79802A (sh) Formulacija sa aktivnošću mobilizacije
SE0000303D0 (sv) Novel compounds
NO20030988L (no) Anvendelse av en sammensetning omfattende et pollenekstrakt for behandlingav hormonrelaterte forstyrrelser
PT1093380E (pt) Componente b como agente angiogenico em combinacao com factores de crescimento humano
DK1086695T3 (da) Antivirale præparater omfattende yohimbin som aktivt princip
ES2165788B1 (es) Empleo de la levadura de cerveza en la elaboracion de un medicamento para el tratamiento del sindrome x fragil.
UY24121A1 (es) Nuevas sulfonamidas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application